Market Closed -
Nasdaq
10:35:10 2024-05-30 EDT
5-day change
1st Jan Change
4.65
USD
+0.87%
+0.43%
-17.26%
Presentation Operator MessageOperator (Operator)Greetings, and welcome to Champions Oncology S...
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
03-15
CI
Craig-Hallum Downgrades Champions Oncology to Hold From Buy
03-13
MT
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
03-12
CI
Transcript : Champions Oncology, Inc., Q3 2024 Earnings Call, Mar 12, 2024
03-12
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
12-13
CI
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating
12-13
MT
Transcript : Champions Oncology, Inc., Q2 2024 Earnings Call, Dec 12, 2023
12-12
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
12-12
CI
MORNING BID AMERICAS-Disinflation station
12-12
RE
North American Morning Briefing : Traders Eye -2-
12-12
DJ
Champions Oncology, Inc. Appoints Brady Davis as President
23-10-17
CI
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating
23-09-22
MT
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
23-09-13
CI
Transcript : Champions Oncology, Inc., Q1 2024 Earnings Call, Sep 13, 2023
23-09-13
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
23-09-13
CI
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies
23-08-01
MT
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
23-08-01
CI
Transcript : Champions Oncology, Inc., Q4 2023 Earnings Call, Jul 24, 2023
23-07-24
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
23-07-24
CI
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023
23-07-24
CI
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023
23-07-24
CI
Champions Oncology Forms Therapeutic Discovery Platform Unit Corellia AI
23-04-17
MT
Champions Oncology, Inc. announces an Equity Buyback for $5 million worth of its shares.
23-04-05
CI
Champions Oncology, Inc. authorizes a Buyback Plan.
23-03-28
CI
Benchmark Company Downgrades Champions Oncology to Hold From Speculative Buy
23-03-16
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The Companyâs TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a-service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverage the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.
More about the company
Last Close Price
4.575
USD
Average target price
6
USD
Spread / Average Target
+31.15%
Consensus
1st Jan change
Capi.
-17.26% 62.67M +52.36% 56.69B -3.86% 41B +38.14% 38.11B -12.01% 26.89B +14.13% 25.59B -21.62% 18.59B +0.21% 12.39B +25.96% 11.99B +23.02% 11.88B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1